Traded Jul 15, 2026 · Filed Jul 16, 2026
Incyte's CMO & Head of Late-Stage Dev. sold $3.19M of Incyte shares. Nobody planned it ahead of time.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$3,192,193
Shares × reported transaction price
78 days after results of Apr 28, 2026, 13 days before results of Jul 28, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $115.09 on Jul 15, 2026, within 3% of its 52-week high, after a 20% rise over the previous 30 trading days
52-week range $67.38 (Jul 21, 2025) to $118.52 (Jul 9, 2026), 93% of the way up, from 251 adjusted closes. 30 trading days earlier: $95.59 on Jun 1, 2026. Describes the past only, not a forecast
None found in footnotes
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | +0.4% | -0.6% | +0.9% |
| 30 days | +5.3% | +4.0% | +1.4% |
Past results only. Not a forecast.
From a 13F filed Aug 14, 2026 covering holdings at Jun 30, 2026 — a quarter-end snapshot, not a live trade.
Officer sold ~$1.31M of Incyte
Automatic sale